Please use this identifier to cite or link to this item:
|Title:||Use of bacterial whole-genome sequencing to understand and improve the management of invasive Staphylococcus aureus infections|
|Authors:||Giulieri, Stefano G;Holmes, Natasha E;Stinear, Timothy P;Howden, Benjamin P|
|Citation:||Expert Review of Anti-infective Therapy 2017; 14(11): 1023-1036|
|Abstract:||Introduction Management of invasive Staphylococcus aureus infections is complex. Dramatic improvements in bacterial whole genome sequencing (WGS) offer new opportunities for personalising the treatment of S. aureus infections. Areas covered: We address recent achievements in S. aureus genomics, describe genetic determinants of antibiotic resistance and summarise studies that have defined molecular characteristics associated with risk and outcome of S. aureus invasive infections. Potential clinical use of WGS for resistance prediction, infection outcome stratification and management of persistent /relapsing infections is critically discussed. Expert commentary: WGS is not only providing invaluable information to track the emergence and spread of important S. aureus clones, but also allows rapid determination of resistance genotypes in the clinical environment. An evolving opportunity is to infer clinically important outcomes and optimal therapeutic approaches from widely available S. aureus genome data, with the goal of individualizing management of invasive S. aureus infections.|
Whole genome sequencing
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.